Regions with REMc-associated Fos-LI increases included the lateral dorsal tegmental (LDT) and pedunculopontine tegmental (PPT) nuclei; the locus coeruleus; the dorsal raphe; and the medial pontine reticular formation. More Fos-LI cells were found with longer REMc bouts than with shorter-duration REMc bouts. However, with 2 hr long REMc bouts the number of Fos-LI cells returned to control levels, suggesting that the c-fos transcriptional cascade is turned off once a threshold of REMc has been reached.
These findings indicate that pontine neuronal populations implicated in REM sleep express more c-fos in the course of REMc, and that the extent of expression is related to the duration of the state. [Key words: c-fos, immediate-early genes, REM sleep, brainstem,
A Ch]
Considerable progress has been made in understanding the physiology, pharmacology, and neuronal mechanisms subserving REM sleep. Lesion and transection studies have shown that REM sleep originates from within the pans, and neuronal activity in this region shows a pattern of discharge that is specifically related to REM sleep (summarized in Steriade and McCarley, 1990) . For instance, during REM sleep locus coeruleus and dorsal raphe cells become virtually silent (McGinty and Harper, 1976; Hobson et al., 1975) . On the other hand, a subpopulation of cholinergic cells in the lateral dorsal tegmental (LDT) and pedunculopontine tegmental (PPT) nuclei (El Mansari et al., 1989; Kayama et al., 1992; Steriade et al., 1990b) , as well as presumptive effector neurons in the medial pontine reticular formation (medial PRF) increase discharge rates (summarized in Steriade and McCarley, 1990) . It is hypothesized that REM sleep is generated as a result of a coordinated interaction between these neuronal groups (summarized in Steriade and McCarley, 1990) .
Investigators have now begun to examine transcriptional responses associated with REM sleep because such events could provide insight into the functional relevance of the periodic brain activation during REM sleep. The initial focus of these efforts has been on the expression of the immediate-early gene (IEG) c-fos during REM sleep. IEGs such as c-fos have been found to be rapidly and transiently expressed in cells in response to cellular stimulation (Morgan et al., 1989; Sheng and Greenberg, 1990; Sagar et al., 1993) . These genes encode proteins that bind to a recognition site on a target gene and promote its expression (Chiu et al., 1988; Franza et al., 1988; Landschulz et al., 1988; Gentz et al., 1989; Turner et al., 1989) . There is a growing body of evidence to suggest that such transcriptional cascades can modify responsivity of the cell to subsequent input and/or influence neuronal plasticity (Sheng and Greenberg, 1990) .
In order to determine whether such cascades are triggered during sleep, c-fos expression has been examined in association with pharmacologically induced REM sleep Yamuy et al., 1993) . Pontine cholinergic mechanisms are hypothesized to be the final effector pathways in REM sleep generation (summarized in Shiromani et al., 1987) . Therefore, microinjection of cholinergic agonists, for example, carbachol, into the media1 pontine reticular formation readily triggers a behavioral state that is indistinguishable from natural REM sleep (George et al., 1964; Baghdoyan et al., 1984; Velazquez-Moctezuma et al., 1989) . Such pharmacological stimulations produce a sustained REM sleep-like state and in this way one can exclude the possibility of c-fi1.r induction by intervening episodes of non-REM sleep or waking. Recently, we found c-j& expression, as determined by the presence of the c-fos protein Fos, in dorsolateral pontine areas during cholinergically induced REM sleep . Yamuy et al. (1993) found that medullary regions that relay the descending signals associated with REM sleep, such as atonia, also showed Fos-like immunoreactivity (Fos-LI) during cholinergically induced REM sleep. Merchant-Nancy et al. (1992) have shown c-fos expression, in rats, in pontine neurons in association with auditory manipulations that prolong REM sleep. These studies show IEG expression in discrete pontine nuclei following manipulations that augment REM sleep. The purpose of the present study was to determine the time course of c-fos expression in specific pontine neuronal populations in response to varying durations of cholinergically induced REM sleep.
Materials and Methods
Subjects and surgical procedures.
Fifteen adult cats weighing 3-5 kg were used. The cat was chosen because the pharmacology and neuronal network subserving REM sleep has been most extensively studied in this species. Under Nembutal anesthesia (35 mglkg, i.v.) and using sterile surgical procedures, the cats were chronically implanted with a standard set of electrodes for recording the electroencephalogram, electromyogram, electro-oculogram, and ponto-geniculo-occipital (PGO) spikes. A stainless steel guide cannula (24 gauge) with a stylette (31 gauge) was implanted in the medial pontine reticular formation (medial PRF) area where cholinergic stimulation reliably produces a sustained REM sleep-like episode (REMc) [target: P 3.0, L 1.8, H -4.5, 0 40", according to Berman's (1968) stereotaxic atlas]. Histological localization of the cannula tips in the medial PRF is depicted in Figure I . Experimental procedures.
Two weeks after recovery from surgery, all cats were given a week of adaptation to the recording conditions and chamber so as to avoid stress associated with handling and unfamiliarity with the sleep-recording environment. The adaptation procedure consisted of the experimenter placing each cat in a cat-restraining bag, sitting for 5 min with the bag in the lap, withdrawing and reinserting the stylette in the guide cannula, and, after an additional minute, releasing the cat from the bag into the sleep-recording chamber. This chamber was a well ventilated, sound attenuated box (62 X 62 X 92 cm) maintained at room temperature (23°C) with food, water, and a litter box. The cats were returned to the vivarium after 3 hr in the sleeprecording chamber. During some adaptation sessions, sleep recordings were obtained for 2 hr in order to examine the patency and integrity of the EEG recording electrodes, cable, and polygraph. The adaptation procedure was followed daily for a week, and the experimental sessions matched the adaptation sessions. All adaptation sessions and experiments were begun at about IO:00 hr.
In all cats, vehicle (0.9% saline), or carbachol microinjections were made with a Hamilton microliter syringe attached via polyethylene tubing to a 31 gauge stainless steel cannula that extended I mm beyond the guide cannula. A total volume of 0.25 pl was slowly and continuously injected. The infusion cannula was left in place for 1 min and then withdrawn and the stylette reinserted. Immediately thereafter, the cats were gently released from the restraining bag into the sleep-recording chamber and polygraphic sleep recordings were made.
In all cats, the polygraphic records were monitored for signs of REM sleep, which included cortical EEG desynchronization, muscle atonia, PGO spikes, and rapid eye movements. In all cats, the end of REM sleep was defined as the resumption of muscle tone for 2 min or longer. In all animals the experimenter did not terminate REMc; rather, the animals spontaneously exited from REMc and were killed by an overdose of Nembutal (intravenous) at appropriate intervals after the end of the REMc bout (schematically depicted in Fig. 1 ). The time from injection of Nembutal to perfusion was about 8 min in all cats.
Immunohistochemisrry.
All brains were perfused via the ascending aorta with 300 ml of ice-cold 0.9% saline followed by 2% formaldehyde in 0.1 M phosphate buffer. The brains were blocked and placed overnight in the fixative and then transferred to 15% sucrose/O.1 M phosphate buffer until equilibration. The pontine brainstem was cut at a thickness of 40 pm on a freezing microtome and one-in-four series (160 pm intervals) of sections were processed for Fos immunohistochemistry using the avidin-biotin procedure with 3,3'-diaminobenzidine (DAB) as the chromogen. A polyclonal antibody against the N-terminal peptide 4-17 of the Fos protein was used (sheep anti-Fos, Cambridge Research Biochemicals) at a dilution of 1:2000. The brains from each animal were processed separately, and to distinguish between specific and nonspecific immunoreactivity, some test sections were not incubated in the antibody.
Datu analysis.
Counts of Fos-LI cells were made in the pontine regions that have been implicated in REM sleep generation. These regions include the cholinergic zone of the lateral dorsal tegmental (LDT) and the pedunculopontine tegmental (PPT) nuclei, the noradrenergic zone of the locus coeruleus (LC), the serotonergic zone of the dorsal raphe, and the medial PRF cells. The monoaminergic and cholinergic cell groups were delineated from our published atlas (Shiromani et al., 1988) and also from our recent study where we have used triplelabeling techniques to visualize cholinergic, noradrenergic (anti-dopamine-p hydroxylase), and serotonergic somata in the same section . Fos-LI cells, clearly visible because of the nuclear staining, were plotted using a computer-based camera lucida system (MicroBrightfield, VT). Counts of Fos-LI-positive cells were made from the side ipsilateral and contralateral to the microinjection site. However, in the medial PRF, counts were made from the contralateral side only. The ipsilateral side was not counted so as to exclude the possibility of counting Fos-LI cells that might have resulted from the injury due to the cannula insertion. The regional expression of Fos-LI was determined without knowledge of vehicle, drug, or length of REMc. For each animal, counts of Fos-LI cells were obtained from every eighth 40 pm section, and on average 12 sections were counted.
The animals were divided on the basis of vehicle versus carbachol, and in the carbachol-treated animals further grouping was based on the duration of sustained REMc bouts. The following six groups were formed: vehicle (n = 3); carbachol controls, 0 min REMc (n = 2); l-25 min REMc (n = 2); 26-50 min REMc (n = 4); 51-75 min REMc (n = 2); and 101-125 min REMc (n = 2). The presence of overall differences was evaluated using a one-way ANOVA. Subsequently, pairwise post hoc comparisons were made using Dunnett's (pairwise comparisons against controls), or Neuman-Keul's (multiple pairwise comparisons) tests. Counts of Fos-LI cells at the P2 level from five animals (F5, F6, F7, F9, and FlO) were published previously as a preliminary report . In that study, only a small portion of the pons (only P2 level) was assessed for Fos-LI and the dorsal raphe was not counted.
Results Figure 1 and Table 1 show the sleepwake profile in all animals in the study. Figure 1A schematically depicts the sleep-wake states in cats receiving vehicle and control carbachol microinjections. Two of the three vehicle-injected animals had spontaneous episodes of REM sleep, but these bouts were interrupted by long bouts of waking and non-REM sleep. Two additional controls were used with manipulation of either the site of microinjection or dose of drug. One carbachol control animal (F17) received a microinjection of carbachol (2 kg/O.25 ~1) in an area lateral to the medial PRE This animal did not have REMc but remained in quiet wakefulness and was killed 63 min after the microinjection. Another animal (F12) received a l/IO the dose of carbachol (0.2 kg/O.25 ~1) into the medial PRF where higher dose of carbachol produced REMc. This animal did not enter into REMc but also remained in quiet wakefulness and was killed 65.6 min after the microinjection. There were no significant differences (independent t test = 0.936) in the number of Fos-LI cells between the vehicle control and carbachol control animals and, therefore, the data from these animals was combined to form one control group. Figure 1B summarizes the sleep-wake states in animals that received 2 +g/O.25 ~1 (n = 9) or 4 kg/O.25 ~1 (n = 1) of carbachol into the medial PRE These animals entered into REMc with an average latency of 8.66 (+ 1.48) min (range, 3.43-17.4 min) after the microinjection. These animals were killed either immediately or at various intervals after the end of the REMc bout (see Fig. lB (Berman, 1968) . killed 60-90 min after microinjection. This is the time period when peak numbers of Fos-LI cells have been shown to occur in another experimental paradigm (Giovannelli et al., 1992) . In all animals, counts of Fos-LI cells were made from the side ipsilateral and contralateral to the microinjection site. There was no significant difference in the number of Fos-LI cells between the ipsilateral versus contralateral sides (t = 1.08; df = 14). P-l Figure 3 . Photomicrographs of Fos-LI cells in the dorsolateral pons in one vehicle (A) and REMc animals. The schematic diagrams identify the location of the photomicrographs. Fos is a nuclear protein and therefore the stained nuclei are visible as round to oval shaped. Often the nucleolus is spared. bc, brachium conjunctivum; FTC, gigantocellular tegmental field; FTP, paralemniscal tegmental field; IC. inferior colliculus; LC, locus coeruleus; LDT, lateral dorsal tegmental nucleus; PPT, pedunculopontine tegmental nucleus; DRN, dorsal raphe nucleus. Scale bar, 100 km.
dorsal raphe, and LC in all animals in the study. For purposes of data analysis the animals were grouped as described previously. Compared to vehicle and carbachol controls (low dose and lateral site injection animals), the animals with REMc showed a significant increase in the number of Fos-LI cells [F(4,14) = 57. Figure 5 indicates that the changes in Fos-LI were not related to the elapsed time from microinjection.
For example, the two carbachol controls that did not have REMc were measured at a similar point in time; that is, 60-70 min after microinjection, compared to two animals with about 1 hr long REMc. The animals with REMc showed Fos-LI while the carbachol controls did not. Similarly, two animals with 15-16 min of REMc were examined at a point in time similar to animals with longer REMc bouts. However, the animals with the shorter REMc bouts had significantly fewer number of Fos-LI cells compared to animals with 1 hr long REMc bouts (P < 0.05). Figure 6 depicts the number of Fos-LI cells in the LC, dorsal
The Journal of Neuroscience, May 1995, I@) 3505 raphe, LDT, and PPT following REMc. This breakdown was done in order to determine whether there were differences in the time course of Fos-LI in these areas. All four neuronal areas showed an increase in the number of Fos-LI cells in response to REMc, with the LDT area showing the greatest number of Fos-LI cells compared to the other three areas (F = 21.75; df = 1;17; P < 0.001). In all four areas the number of Fos-LI cells declined after 2 hr continuous REMc.
Aside from the monoaminergic/cholinergic areas, another area in the pons that was examined in detail was the medial PRE This is the area from which cholinergic agonists readily induce REMc. The microinjections were made in the medial PRF and the site of the injection typically showed a high level of Fos-LI cells in all animals. Some of these cells were found to be GFAP (glial fibrillary acidic protein, a putative marker of glial cells) positive, suggesting the induction of c-fos in response to injury resulting from the cannula insertion. Counts of Fos-LI cells were made in the medial PRF area contralateral to the microinjection site. The ipsilateral side was not counted because high levels of Fos-LI were seen in all animals and this may be in response to injury resulting from the cannula insertion. Figure 7 summarizes the results of the number of Fos-LI cells in the contralateral medial PRE Generally, the number of Fos-LI cells were fewer compared to the LDT/PPT, LC, and dorsal raphe. However, the time course of Fos-LI was similar to the other groups.
Fos-LI in other brain regions
Many brain regions showed some Fos-LI cells regardless of treatment. For instance, the ventral pontine area showed numerous Fos-LI cells in all animals. Specific counts of Fos-LI cells in these and other regions were not obtained because no obvious difference, based on a visual inspection, related to the various treatments was found to occur. However, we cannot rule out the possibility that subtle changes in the number of Fos-LI cells related to REMc could have occurred in these regions.
Particular emphasis was placed on regions implicated in generating the tonic and phasic aspects of REM sleep. For instance, 8 activity is recorded during REM sleep and during some purposeful behaviors in the hippocampus (Winson, 1972) . There were no clearly evident differences in the number of Fos-LI cells . Same data as in Figure 4 but in this figure the data are plotted as a function of elapsed time from microinjection of drug or vehicle. Vehicle and carbachol control animals were examined at the time point when peak levels of Fos-LI were expected, based on evidence from another experimental manipulation (Giovannelli et al., 1992) . The number of Fos-LI cells was not influenced by the elapsed time from the microinjection. Rather, a higher number of Fos-LI cells occurred in con-40  50  60  70  80  90  100  110  120  130  14 junction with REMc. The subject iden-
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in the various hippocampal fields and the dentate gyrus in the vehicle versus animals with REMc. Similarly, we could not find any noticeable change in the number of Fos-LI cells in the lateral geniculate nucleus. This is the area from where PGO waves are most easily recorded in the cat and these waves are present immediately before and during REM sleep. PGO waves are hypothesized to be triggered by PGO-burst neurons and other PGO-related neurons in the LDT-PPT (McCarley et al., 1978; Steriade et al., 1990b) . In our study, the presence of PGO waves was used to confirm REMc and these waves were elicited whenever REMc occurred. Therefore, it is interesting that even when PGO waves were present with.2 hr long REMc bouts, the LGN failed to show Fos-LI cells above basal levels. Other thalamic sites also subserve REM sleep-related functions such as medi- ating the cortical desynchronization that occurs during waking and REM sleep (Steriade et al., 1990a) . We found that Fos-LI was always present in various thalamic areas, such as the dorsomedial, central, ahd ventrobasal areas. The medial habenula also contained high numbers of Fos-LI regardless of treatment. Similarly, the visual cortical layers did not show a change in Fos-LI, which could be attributed to REMc.
Discussion
In the present study, we examined for the first time the time course of Fos-LI in discrete pontine nuclei in response to varying durations of REMc, and we have also controlled for the effects of carbachol microinjections. These findings are necessary in order to understand the transcriptional process during natural sleep. Compared to vehicle or carbachol controls, animals with REMc had a significantly higher number of Fos-LI cells in discrete pontine regions implicated in REM sleep generation. More Fos-LI cells were seen with 1 hr long REMc bouts compared to shorter or longer REMc bouts. In this study, cholinergic stimulation was used to trigger REMc. Cholinergic drugs have been shown to rapidly induce a state that resembles REM sleep in rats, cats, dogs, and humans (reviewed in Shiromani et al., 1987) . In cats, microinjections of carbachol, a mixed cholinergic agonist, into the medial PRF trigger REM sleep (George et al., 1964; Baghdoyan et al., 1987) . The drug-induced REM sleep is similar in many respects to normal REM sleep in terms of cardiovascular changes Lydic et al., 1989) and acetylcholine (ACh) release (Lydic et al., 1991) . The motoneuron inhibition responsible for the atonia of REM sleep is similar during REMc and physiological REM sleep (Morales et al., 1987) . Putative serotonergic cells are silent during REMc just like in physiological REM sleep (Steinfels et al., 1983) , and the change in activity of medial PRF neurons has been shown to be temporally related to the emergence of the carbachol-induced REM sleep . Greene et al. (1989) used the in vitro pontine slice preparation b show that a majority of medial PRF neurons respond-ed to carbachol and the membrane depolarization was similar to that obtained during physiological REM sleep (Ito et al., 1984) .
In the present study, cholinergic stimulation alone was not sufficient to induce Fos-LI. For instance, the effects of carbachol in inducing REMc and Fos-LI were confined to the medial PRE Microinjection of carbachol outside the medial PRF area, or injections of a lower dose of carbachol into the medial PRE did not trigger REMc and the number of Fos-LI cells were statistically comparable to vehicle controls. These findings agree with recent data which showed that in the suprachiasmatic nucleus microinjection of carbachol was not sufficient by itself to trigger Fos-LI (Colwell et al., 1993) . Thus, it is clear that in the present study, changes in Fos-LI were not simply the result of carbachol administration but also dependent on the elicitation of an REMlike state.
We found increased numbers of Fos-LI cells in the LDT, PPT, LC, dorsal raphe, and the medial PRF (counting the side contralateral to the microinjection). These areas are distant from the carbachol microinjection sites, implying transynaptic effects leading to c-fos expression. Moreover, diffusion of the drug cannot explain the effects because Fos-LI cells were found to be equally distributed in monoaminergic and chohnergic regions ipsilateral and contralateral to the microinjection site. Neurons in the LDT, PPT, LC, dorsal raphe, and medial PRF have been implicated in producing REM sleep, and both intracellular and extracellular unit studies have shown that these neurons exhibit marked changes in firing rates in relation to REM sleep (Steriade and McCarley, 1990) . The presence of Fos-LI in these areas suggests coordinated changes in a network underlying REMc. The viability of such a network in evoking REMc and Fos-LI is further confirmed by our finding that stimulation by carbachol of neurons outside this network did not evoke REMc or Fos-LI.
The intracellular mechanism leading to c-fos expression in the LDT, PPT, LC, dorsal raphe, and medial PRF is unclear at this time. However, NMDA-mediated calcium entry might be involved because recent evidence shows a strong role of glutaminergic pathways in evoking REM sleep components (Lai et al., 1991) . Transcription of the c-fos gene has been shown to occur in response to increases in CAMP or calcium which phosphorylate a CAMP/calcium response element binding protein (CREB) (Sheng et al., 1990 (Sheng et al., , 1991 . However, phosphorylation of CREB might be only one of the events leading to c&s transcription (Shiromani et al., 1994) . Increased numbers of Fos-LI cells were found in the LDT compared to the other pontine groups. The LDT along with the adjoining PPT area contains cholinergic cells, and these cells are considered prime candidates for orchestrating the various neuronal elements related to the REM sleep process (reviewed in Shiromani et al., 1988) . The higher number of Fos-LI cells in the LDT suggests a greater participation of cells in this neuronal group in the REMc process. A subpopulation of cells in the LDT have been found to increase discharge selectively during REM sleep (Steriade et al., 1990; Kayama et al., 1992) . However, the temporal change in Fos-LI in the LDT in response to REMc was similar to the other pontine neuronal populations. This further suggests that there is a synchronized interplay between various neuronal populations in orchestrating the REMc process. The role of a subpopulation of LDT-PPT cholinergic neurons in the REM sleep process is further supported by our preliminary analysis, which has revealed that some of the cholinergic cells are also Fos-LI positive (Shiromani et al., work in progress).
Interestingly, in the present study, increased numbers of Fos-LI cells were found in the LC and dorsal raphe where neuronal activity typically ceases during normal REM sleep (Hobson et al., 1975; McGinty and Harper, 1976) . Putative serotonergic neurons are also silent during REMc (Steinfels et al., 1983) . However, Lydic et al. have found high metabolic activity in these areas in conjunction with normal REM sleep (Lydic et al., 199 1) . We suggest that these effects might be representative of increased discharge of GABA interneurons. Increased release of GABA as measured by microdialysis has been noted during natural REM sleep in the dorsal raphe (Nitz et al., 1993) .
In this study we found that Fos-LI was related to the duration of REMc; maximal numbers of Fos-LI cells were found with 1 hr continuous REMc compared with shorter and longer REMc bouts. Previously, noted that the activity of medial PRF and other pontine neurons was temporally related to the emergence and decline of REMc. We have now shown that transcriptional coding in discrete pontine neurons is also temporally related to the duration of REMc. Perhaps c-fos expression is turned off once neuronal activity reaches critical levels. However, more sophisticated techniques that focus on mRNA levels will be needed to fully understand the temporal relationship between c-&s transcription and REM sleep. The presence of Fos-LI in populations of REM sleep effector neurons could provide clues about the functional relevance of the REM sleep state. For instance, it has been suggested that transcription factors such as Fos can modify the response of the neuron to subsequent input (Sheng and Greenberg, 1990 ). Therefore, it is possible that such transcriptional cascades, in pools of neurons, might code for intracellular events that reset the "need" for REM sleep, maintain synaptic efficacy and homeostasis in neuronal clusters, or, in the young, promote growth and development.
Previously, before IEG expression was known, various investigators had suggested similar functions for REM sleep (see Webb, 1981) .
